Literature DB >> 30515941

Liraglutide and systolic blood pressure.

Paresh Dandona1,2, Husam Ghanim1,2, Ajay Chaudhuri1,2.   

Abstract

Entities:  

Keywords:  cardioprotective; liraglutide; systolic blood pressure; vasodilation

Mesh：

Substances：

Year:  2018        PMID： 30515941      PMCID： PMC8030325          DOI： 10.1111/jch.13443

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  23 in total

1.  Liraglutide as additional treatment to insulin in obese patients with type 1 diabetes mellitus.

Authors:  Nitesh D Kuhadiya; Ritu Malik; Natalie J Bellini; Jane Lyons Patterson; Andrea Traina; Antoine Makdissi; Paresh Dandona
Journal:  Endocr Pract       Date:  2013 Nov-Dec       Impact factor: 3.443

2.  Exenatide induces an increase in vasodilatory and a decrease in vasoconstrictive mediators.

Authors:  Ajay Chaudhuri; Husam Ghanim; Antoine Makdissi; Kelly Green; Sanaa Abuaysheh; Manav Batra; Nitesh D Kuhadiya; Paresh Dandona
Journal:  Diabetes Obes Metab       Date:  2017-02-22       Impact factor: 6.577

3.  Insulin-induced vasodilatation of internal carotid artery.

Authors:  A Chaudhuri; Y Kanjwal; P Mohanty; S Rao; B H Sung; M F Wilson; P Dandona
Journal:  Metabolism       Date:  1999-11       Impact factor: 8.694

4.  Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes.

Authors:  P Mohanty; W Hamouda; R Garg; A Aljada; H Ghanim; P Dandona
Journal:  J Clin Endocrinol Metab       Date:  2000-08       Impact factor: 5.958

5.  Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.

Authors:  Ananda Basu; Nisha Charkoudian; William Schrage; Robert A Rizza; Rita Basu; Michael J Joyner
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-08-21       Impact factor: 4.310

6.  Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.

Authors:  Prabhakar Viswanathan; Ajay Chaudhuri; Ruchi Bhatia; Fida Al-Atrash; Priya Mohanty; Paresh Dandona
Journal:  Endocr Pract       Date:  2007-09       Impact factor: 3.443

7.  Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

Authors:  P Dandona; A Aljada; P Mohanty; H Ghanim; W Hamouda; E Assian; S Ahmad
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

8.  Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes.

Authors:  Juraj Koska; Eric A Schwartz; Michael P Mullin; Dawn C Schwenke; Peter D Reaven
Journal:  Diabetes Care       Date:  2010-03-03       Impact factor: 19.112

9.  Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

Authors:  H O Steinberg; G Brechtel; A Johnson; N Fineberg; A D Baron
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes.

Authors:  Guillermo E Umpierrez; Dawn Smiley; Gonzalo Robalino; Limin Peng; Abbas E Kitabchi; Bobby Khan; Ahn Le; Arshed Quyyumi; Virgil Brown; Lawrence S Phillips
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.